Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Jun 26, 2019
| Jennifer Soup
GRx+Biosims 2019: Register Now and Be Part of the Solution
Press Release
Jun 26, 2019
| Jewel Smith
AAM Announces New 2019 Members
Blog
Jun 25, 2019
| Erik Komendant
Section 205 is Still Flawed and Erodes the Only Incentive to Challenge Brand-Name Drug Patents. Here’s Why.
Report
Jun 25, 2019
| Christine Simmon
White Paper (Part 1) Failure to Launch: Patent Abuse Blocks Access to Biosimilars for America's Patients
Blog
Jun 19, 2019
| Chip Davis
Congress: Don’t Punish American Patients
Blog
May 29, 2019
| Erica Klinger
Five Lessons from a National Collaboration to Promote Prescription Drug Safety
Video
May 29, 2019
| Erica Klinger
American Patients Must Tell Congress to Fix the USMCA to Lower Drug Prices!
Blog
May 28, 2019
| Jewel Smith
Join AAM Today!
Press Release
May 23, 2019
| Rachel Schwartz
AAM Statement on FTC Report on Patent Settlements
Blog
May 23, 2019
| Erica Klinger
WiHP Event Features Congressional Speaker
Press Release
May 21, 2019
| Rachel Schwartz
AAM Statement on House Bills 965, 1499 and 938
Press Release
May 17, 2019
| Rachel Schwartz
AAM Statement on the Importance of Generic and Biosimilar Quality and Robust Competition
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action